Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
about
Mismatch Negativity in First-Episode Schizophrenia: A Meta-Analysis.A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in miceConsensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patientsFree D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammalsPartial genetic deletion of neuregulin 1 and adolescent stress interact to alter NMDA receptor binding in the medial prefrontal cortex.mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia.Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity.MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children.Biosynthesis of D-aspartate in mammals: the rat and human homologs of mouse aspartate racemase are not responsible for the biosynthesis of D-aspartate.D-Amino Acids in the Nervous and Endocrine Systems.Quantitative determination of free D-Asp, L-Asp and N-methyl-D-aspartate in mouse brain tissues by chiral separation and Multiple Reaction Monitoring tandem mass spectrometry.Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates.Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial.DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia.The Emerging Role of Altered d-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies
P2860
Q30250337-F26D5EE6-3058-43DC-959C-B1F1DF33857CQ30651885-FAAA91D4-868F-41E3-9BAD-46E67B746927Q31108616-269DA6DE-AC20-4BDB-82F8-97F9E20DA87EQ33718794-F34070F2-6EF8-456E-A1C6-BE17B3AE713CQ33990671-7ECDAF9F-58F8-46C6-8635-4CA2A54FE3ADQ34264958-46F8A1A4-B4F5-46BE-A0AD-25887F23EF48Q34513221-55989E4D-A977-4A43-BA83-2B0592896B2BQ36848319-DEC17E07-8460-47D1-876D-6E82DF14CB5FQ37743256-7653794E-79E7-4904-BE31-8B7D445B371DQ38267957-9E4713AD-307C-4D7F-85A4-6C86C7CEF410Q38839164-A60BBE4E-4D09-4631-B10E-DDDFA5735C14Q38913507-60282A1D-454C-45A1-B016-C6A6A9360447Q39067787-AE476023-8F2E-47B0-84A8-04DAB31AF9F3Q41002296-FDB8323A-F41F-45C8-80C0-49D46163FDDCQ41950823-D5C3A788-C9D9-419B-9FE1-EAA3F77878A2Q50750840-B6EE7DB7-79E6-433E-90A6-149BEDAE52BCQ55717695-F87A9A13-D87B-4340-B3DC-4A2ECC2484CBQ59127815-93E39DE9-4240-4879-8E6C-9273583D8141
P2860
Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Decreased levels of D-aspartat ...... f patients with schizophrenia.
@en
Decreased levels of D-aspartat ...... f patients with schizophrenia.
@nl
type
label
Decreased levels of D-aspartat ...... f patients with schizophrenia.
@en
Decreased levels of D-aspartat ...... f patients with schizophrenia.
@nl
prefLabel
Decreased levels of D-aspartat ...... f patients with schizophrenia.
@en
Decreased levels of D-aspartat ...... f patients with schizophrenia.
@nl
P2093
P50
P921
P1476
Decreased levels of D-aspartat ...... of patients with schizophrenia
@en
P2093
Alessandro Bertolino
Antimo D'Aniello
Daniela Vitucci
P304
P356
10.1016/J.JPSYCHIRES.2013.06.013
P50
P577
2013-07-06T00:00:00Z